• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

社论：固定剂量复方钙泊三醇/倍他米松二丙酸酯泡沫剂治疗银屑病患者。

Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis.

机构信息

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, UK.

出版信息

J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):3-4. doi: 10.1111/jdv.17026.

DOI:10.1111/jdv.17026
PMID:33619781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8151871/
Abstract

Video abstract

摘要

视频摘要

相似文献

1
Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis.社论：固定剂量复方钙泊三醇/倍他米松二丙酸酯泡沫剂治疗银屑病患者。
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):3-4. doi: 10.1111/jdv.17026.
2
Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile.卡泊三醇倍他米松二丙酸酯固定复方气雾剂泡沫治疗寻常型银屑病：研发原理与临床概况
Expert Opin Pharmacother. 2017 Jan;18(1):115-121. doi: 10.1080/14656566.2016.1269749.
3
Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.钙泊三醇/倍他米松二丙酸酯泡沫：斑块状银屑病的研究进展。
Drugs. 2016 Oct;76(15):1485-1492. doi: 10.1007/s40265-016-0643-7.
4
Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.使用含卡泊三醇和二丙酸倍他米松的新型复方产品治疗点滴状银屑病。
Int J Clin Pharmacol Res. 2005;25(4):165-8.
5
The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.DESIRE 研究——在日常临床实践中使用卡泊三醇和倍他米松二丙酸酯固定复方制剂治疗银屑病患者的满意度。
Eur J Dermatol. 2009 Nov-Dec;19(6):581-5. doi: 10.1684/ejd.2009.0767. Epub 2009 Sep 2.
6
Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.卡泊三醇倍他米松二丙酸酯凝胶治疗身体及头皮银屑病的汇总安全性分析
J Eur Acad Dermatol Venereol. 2014 May;28 Suppl 2:10-21. doi: 10.1111/jdv.12444.
7
Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.外用卡泊三醇/倍他米松二丙酸酯治疗寻常型银屑病：一项系统评价。
Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):135-44. doi: 10.4103/0378-6323.175919.
8
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.一种作用起效迅速的新钙泊三醇/倍他米松制剂在寻常型银屑病治疗中优于倍他米松二丙酸酯或钙泊三醇单药治疗。
Acta Derm Venereol. 2002;82(2):131-5. doi: 10.1080/00015550252948194.
9
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.聚焦于钙泊三醇倍他米松在躯干、四肢和头皮寻常型银屑病中的应用。
Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000.
10
Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.卡泊三醇倍他米松二丙酸酯复方创新气雾剂泡沫制剂治疗寻常型银屑病的疗效
Clin Drug Investig. 2015 Apr;35(4):239-45. doi: 10.1007/s40261-015-0269-7.

本文引用的文献

1
Calcipotriol/betamethasone dipropionate foam demonstrates comparable efficacy to clinical trial data in the real world, improves patient satisfaction and is cost-effective.卡泊三醇/倍他米松二丙酸酯泡沫剂在现实世界中的疗效与临床试验数据相当，能提高患者满意度且具有成本效益。
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1:28-34. doi: 10.1111/jdv.17084.
2
Early efficacy and safety data with fixed-dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency.固定剂量复方钙泊三醇/倍他米松二丙酸酯泡沫剂的早期疗效和安全性数据归因于吸收机制和类固醇效能。
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):5-9. doi: 10.1111/jdv.17027.
3
Fixed-dose combination calcipotriol/betamethasone dipropionate foam provides a rapid onset of action, effective itch relief and improves patient quality of life.固定剂量复方卡泊三醇/倍他米松二丙酸酯泡沫起效迅速，能有效缓解瘙痒并改善患者生活质量。
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):20-27. doi: 10.1111/jdv.17085.
4
Efficacy and safety of fixed-dose combination calcipotriol/betamethasone dipropionate foam for the treatment of psoriasis.固定剂量复方卡泊三醇/倍他米松二丙酸酯泡沫治疗银屑病的疗效与安全性
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1:10-19. doi: 10.1111/jdv.17028.
5
Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis.应对银屑病患者长期局部治疗相关挑战及积极管理的益处。
J Eur Acad Dermatol Venereol. 2021 Feb;35 Suppl 1(Suppl 1):35-41. doi: 10.1111/jdv.17053.
6
Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study.卡泊三醇倍他米松二丙酸酯气雾剂泡沫剂治疗寻常型银屑病的疗效优于凝胶剂：随机对照PSO-ABLE研究
J Eur Acad Dermatol Venereol. 2017 Jan;31(1):119-126. doi: 10.1111/jdv.13859. Epub 2016 Aug 17.
7
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.卡泊三醇倍他米松二丙酸酯气雾剂泡沫剂与软膏剂治疗寻常型银屑病疗效对比——一项随机II期研究
J Dermatolog Treat. 2016;27(2):120-7. doi: 10.3109/09546634.2015.1083935. Epub 2015 Oct 7.
8
Compatibility of calcipotriene with other topical medications.卡泊三醇与其他局部用药物的相容性。
J Am Acad Dermatol. 1998 Jun;38(6 Pt 1):1010-1. doi: 10.1016/s0190-9622(98)70171-9.
9
A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.一项关于卡泊三醇软膏和卤米松软膏与单用其中任一药物治疗银屑病的多中心试验。
J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):268-9. doi: 10.1016/s0190-9622(96)90349-7.
10
Betamethasone dipropionate in optimized vehicle. Intermittent pulse dosing for extended maintenance treatment of psoriasis.丙酸倍他米松，采用优化载体。间歇性脉冲给药用于银屑病的长期维持治疗。
Arch Dermatol. 1987 Oct;123(10):1308-11. doi: 10.1001/archderm.123.10.1308.